TherapeuticAI®
How TherapeuticAI® supports child development at scale
TherapeuticAI® supports child development at population scale by standardising developmental observation, surfacing district-level patterns from de-identified data, and prioritising children for a clinician-led check — strengthening the screening-to-referral pathway without diagnosing. A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
When child development is measured well at scale, every family — not just those who reach a centre — can be reached in time.
In short
TherapeuticAI® supports child development at population scale by turning routine developmental observation into structured, comparable, privacy-respecting data — so that governments and public-health systems can see where need is rising, where therapy capacity is thin, and which children should be prioritised for a proper clinical check. It does not diagnose or replace clinicians; it strengthens the screening-to-referral pathway across whole districts. Built on a foundation of 2.5 billion+ data points and 25 million+ therapy sessions, it is designed to extend reach without diluting clinical rigour.How it works at population scale
- Standardised developmental signal capture — front-line workers (Anganwadi, ASHA, school health teams) record consistent, age-appropriate observations through a guided interface, reducing variation between observers.
- Population-level intelligence, not labels — aggregated, de-identified data shows district and block-level patterns: emerging delay clusters, under-served regions, and demand for speech, occupational and behavioural support.
- Prioritised routing — children showing meaningful early indicators are flagged for a structured clinician-led assessment, so scarce specialist time reaches those who need it most.
- Capacity planning — public programmes can map therapist supply against demonstrated demand across a 70+ centre, 700+ therapist network spanning 4 states, informing where to grow services.
- Equity by design — multilingual, mobile-first delivery extends the same quality of early observation to rural and low-resource settings.
The aim is earlier identification and faster, fairer access to qualified care — never an automated verdict on any individual child.
Governance and scope
TherapeuticAI® operates as decision-support for public-health and developmental screening; it sits outside the regulated diagnostic pathway and makes no clinical determination. Pinnacle's diagnostic clinical assessment is a separate, CDSCO Class B SaMD process administered only by qualified clinicians. This separation is deliberate: population tools widen the net; clinicians make the call. The platform is underpinned by 16+ WIPO PCT patents and 12 validated studies.The Pinnacle way
A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care — never by an algorithm or population dashboard. Population data identifies who may benefit from a closer look; the structured clinician assessment does the rest, and children then enter tailored support such as speech therapy. Learn more about our [approach](/).Trusted sources
WHO Nurturing Care Framework on early childhood development at system scale; WHO guidance on improving early childhood development; CDC developmental monitoring and screening principles; Rehabilitation Council of India standards for service delivery.Next step — Exploring population-scale developmental screening for your district or programme? [Partner with Pinnacle Blooms Network](/).
This is general information, not a diagnosis — a clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
What to watch
At population level, watch for under-served districts where developmental indicators rise but therapy capacity is thin, observer-to-observer variation in screening, and gaps between flagged children and completed clinician assessments — these signal where referral pathways need strengthening.
Try this at home
Pair every screening tool with a clear, funded route to a qualified clinician — data that flags need is only useful when a real assessment and real therapy reliably follow.
Trusted sources
Developed by SETU Consortium · Pinnacle Blooms Network · Last reviewed 2026-06-10 · reviewed every 365 days
This is general information, not a diagnosis. A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care.
Frequently asked
Does TherapeuticAI® diagnose children?
No. TherapeuticAI® supports population-scale developmental screening and prioritised referral; it never diagnoses. A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
How does it help governments and public-health programmes?
It standardises developmental observation by front-line workers, surfaces de-identified district and block-level patterns of need and capacity, and prioritises children for a clinician-led assessment — helping programmes target scarce specialist resources fairly.
Is it a regulated medical device?
TherapeuticAI® as a population-screening and decision-support tool sits outside the regulated diagnostic pathway. Pinnacle's separate clinician-administered diagnostic assessment is a CDSCO Class B SaMD process.